Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5
Clinical trial NCT06284122 · RECRUITING
Trial details
- NCT number
- NCT06284122
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-07
- Primary completion
- 2028-11-01
- Enrollment
- 790
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.